Cargando…

Functional characterization of two enhancers located downstream FOXP2

BACKGROUND: Mutations in the coding region of FOXP2 are known to cause speech and language impairment. However, it is not clear how dysregulation of the gene contributes to language deficit. Interestingly, microdeletions of the region downstream the gene have been associated with cognitive deficits....

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Ruiz, Raúl, Benítez-Burraco, Antonio, Martínez-Lage, Marta, Rodríguez-Perales, Sandra, García-Bellido, Paloma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498672/
https://www.ncbi.nlm.nih.gov/pubmed/31046704
http://dx.doi.org/10.1186/s12881-019-0810-2
_version_ 1783415662186594304
author Torres-Ruiz, Raúl
Benítez-Burraco, Antonio
Martínez-Lage, Marta
Rodríguez-Perales, Sandra
García-Bellido, Paloma
author_facet Torres-Ruiz, Raúl
Benítez-Burraco, Antonio
Martínez-Lage, Marta
Rodríguez-Perales, Sandra
García-Bellido, Paloma
author_sort Torres-Ruiz, Raúl
collection PubMed
description BACKGROUND: Mutations in the coding region of FOXP2 are known to cause speech and language impairment. However, it is not clear how dysregulation of the gene contributes to language deficit. Interestingly, microdeletions of the region downstream the gene have been associated with cognitive deficits. METHODS: Here, we investigate changes in FOXP2 expression in the SK-N-MC neuroblastoma human cell line after deletion by CRISPR-Cas9 of two enhancers located downstream of the gene. RESULTS: Deletion of any of these two functional enhancers downregulates FOXP2, but also upregulates the closest 3′ gene MDFIC. Because this effect is not statistically significant in a HEK 293 cell line, derived from the human kidney, both enhancers might confer a tissue specific regulation to both genes. We have also found that the deletion of any of these enhancers downregulates six well-known FOXP2 target genes in the SK-N-MC cell line. CONCLUSIONS: We expect these findings contribute to a deeper understanding of how FOXP2 and MDFIC are regulated to pace neuronal development supporting cognition, speech and language. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-019-0810-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6498672
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64986722019-05-09 Functional characterization of two enhancers located downstream FOXP2 Torres-Ruiz, Raúl Benítez-Burraco, Antonio Martínez-Lage, Marta Rodríguez-Perales, Sandra García-Bellido, Paloma BMC Med Genet Research Article BACKGROUND: Mutations in the coding region of FOXP2 are known to cause speech and language impairment. However, it is not clear how dysregulation of the gene contributes to language deficit. Interestingly, microdeletions of the region downstream the gene have been associated with cognitive deficits. METHODS: Here, we investigate changes in FOXP2 expression in the SK-N-MC neuroblastoma human cell line after deletion by CRISPR-Cas9 of two enhancers located downstream of the gene. RESULTS: Deletion of any of these two functional enhancers downregulates FOXP2, but also upregulates the closest 3′ gene MDFIC. Because this effect is not statistically significant in a HEK 293 cell line, derived from the human kidney, both enhancers might confer a tissue specific regulation to both genes. We have also found that the deletion of any of these enhancers downregulates six well-known FOXP2 target genes in the SK-N-MC cell line. CONCLUSIONS: We expect these findings contribute to a deeper understanding of how FOXP2 and MDFIC are regulated to pace neuronal development supporting cognition, speech and language. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12881-019-0810-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-02 /pmc/articles/PMC6498672/ /pubmed/31046704 http://dx.doi.org/10.1186/s12881-019-0810-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Torres-Ruiz, Raúl
Benítez-Burraco, Antonio
Martínez-Lage, Marta
Rodríguez-Perales, Sandra
García-Bellido, Paloma
Functional characterization of two enhancers located downstream FOXP2
title Functional characterization of two enhancers located downstream FOXP2
title_full Functional characterization of two enhancers located downstream FOXP2
title_fullStr Functional characterization of two enhancers located downstream FOXP2
title_full_unstemmed Functional characterization of two enhancers located downstream FOXP2
title_short Functional characterization of two enhancers located downstream FOXP2
title_sort functional characterization of two enhancers located downstream foxp2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498672/
https://www.ncbi.nlm.nih.gov/pubmed/31046704
http://dx.doi.org/10.1186/s12881-019-0810-2
work_keys_str_mv AT torresruizraul functionalcharacterizationoftwoenhancerslocateddownstreamfoxp2
AT benitezburracoantonio functionalcharacterizationoftwoenhancerslocateddownstreamfoxp2
AT martinezlagemarta functionalcharacterizationoftwoenhancerslocateddownstreamfoxp2
AT rodriguezperalessandra functionalcharacterizationoftwoenhancerslocateddownstreamfoxp2
AT garciabellidopaloma functionalcharacterizationoftwoenhancerslocateddownstreamfoxp2